{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:47:17Z","timestamp":1793929637032,"version":"4.8.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["DFF-2096-00144B"],"award-info":[{"award-number":["DFF-2096-00144B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["DFF-2096-00144B"],"award-info":[{"award-number":["DFF-2096-00144B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["DFF-2096-00144B"],"award-info":[{"award-number":["DFF-2096-00144B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["DFF-2096-00144B"],"award-info":[{"award-number":["DFF-2096-00144B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["DFF-2096-00144B"],"award-info":[{"award-number":["DFF-2096-00144B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["DFF-2096-00144B"],"award-info":[{"award-number":["DFF-2096-00144B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["DFF-2096-00144B"],"award-info":[{"award-number":["DFF-2096-00144B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"DOI":"10.1007\/s10875-025-01977-w","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:53:16Z","timestamp":1766537596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Signatures of Trained Immunity Following mRNA Vaccination: Differences Between mRNA-1273 and BNT162b2"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5297-2846","authenticated-orcid":false,"given":"Martin","family":"Kunc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3594-4979","authenticated-orcid":false,"given":"Bradley Joseph","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2459-0511","authenticated-orcid":false,"given":"Lars J\u00f8rgen","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7020-5173","authenticated-orcid":false,"given":"Martin","family":"Tolstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6102-3810","authenticated-orcid":false,"given":"Christine Stabell","family":"Benn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2534-2942","authenticated-orcid":false,"given":"Christian Morberg","family":"Wejse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6673-8505","authenticated-orcid":false,"given":"Peter","family":"Nejsum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"issue":"16","key":"1977_CR1","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.1073\/pnas.86.16.6077","volume":"86","author":"RW Malone","year":"1989","unstructured":"Malone RW, Felgner PL, Verma IM. Cationic liposome-mediated RNA transfection. Proc Natl Acad Sci U S A. 1989;86(16):6077\u201381. https:\/\/doi.org\/10.1073\/pnas.86.16.6077.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1977_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ijid.2020.08.043","volume":"98","author":"E Petersen","year":"2020","unstructured":"Petersen E, Wejse C, Zumla A. Advancing COVID-19 vaccines - avoiding different regulatory standards for different vaccines and need for open and transparent data sharing. Int J Infect Dis. 2020;98:501\u20132. https:\/\/doi.org\/10.1016\/j.ijid.2020.08.043.","journal-title":"Int J Infect Dis"},{"issue":"11","key":"1977_CR3","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","volume":"55","author":"R Verbeke","year":"2022","unstructured":"Verbeke R, Hogan MJ, Lore K, Pardi N. Innate immune mechanisms of mRNA vaccines. Immunity. 2022;55(11):1993\u20132005. https:\/\/doi.org\/10.1016\/j.immuni.2022.10.014.","journal-title":"Immunity"},{"key":"1977_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9020081","author":"I Knezevic","year":"2021","unstructured":"Knezevic I, Liu MA, Peden K, Zhou T, Kang HN. Development of mRNA vaccines: scientific and regulatory issues. Vaccines. 2021. https:\/\/doi.org\/10.3390\/vaccines9020081.","journal-title":"Vaccines"},{"key":"1977_CR5","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.omtn.2023.04.021","volume":"32","author":"G Lin","year":"2023","unstructured":"Lin G, Yan H, Sun J, Zhao J, Zhang Y. Self-replicating RNA nanoparticle vaccine elicits protective immune responses against SARS-CoV-2. Mol Ther Nucleic Acids. 2023;32:650\u201366. https:\/\/doi.org\/10.1016\/j.omtn.2023.04.021.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"1977_CR6","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/s41467-025-55843-9","volume":"16","author":"CJ Maine","year":"2025","unstructured":"Maine CJ, Miyake-Stoner SJ, Spasova DS, Picarda G, Chou AC, Brand ED, et al. Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label phase I study in healthy volunteers. Nat Commun. 2025;16(1):456. https:\/\/doi.org\/10.1038\/s41467-025-55843-9.","journal-title":"Nat Commun"},{"issue":"1","key":"1977_CR7","doi-asserted-by":"publisher","first-page":"21232","DOI":"10.1038\/s41598-022-25134-0","volume":"12","author":"CS Korosec","year":"2022","unstructured":"Korosec CS, Farhang-Sardroodi S, Dick DW, Gholami S, Ghaemi MS, Moyles IR, Craig M, Ooi HK, Heffernan JM. Long-term durability of immune responses to the BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex. Sci Rep. 2022;12(1):21232. https:\/\/doi.org\/10.1038\/s41598-022-25134-0.","journal-title":"Sci Rep"},{"key":"1977_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijid.2022.08.022","volume":"123","author":"WM Brunner","year":"2022","unstructured":"Brunner WM, Freilich D, Victory J, Krupa N, Scribani MB, Jenkins P, Lasher EG, Fink A, Shah A, Cross P, Bush V, Peek LJ, Pestano GA, Gadomski AM. Comparison of antibody response durability of mRNA-1273, BNT162b2, and Ad26.COV2.S SARS-CoV-2 vaccines in healthcare workers. Int J Infect Dis. 2022;123:183\u201391. https:\/\/doi.org\/10.1016\/j.ijid.2022.08.022.","journal-title":"Int J Infect Dis"},{"key":"1977_CR9","doi-asserted-by":"publisher","first-page":"1204831","DOI":"10.3389\/fimmu.2023.1204831","volume":"14","author":"X Wang","year":"2023","unstructured":"Wang X, Haeussler K, Spellman A, Phillips LE, Ramiller A, Bausch-Jurken MT, Sharma P, Krivelyova A, Vats S, Van de Velde N. Comparative effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in immunocompromised individuals: a systematic review and meta-analysis using the GRADE framework. Front Immunol. 2023;14:1204831. https:\/\/doi.org\/10.3389\/fimmu.2023.1204831.","journal-title":"Front Immunol"},{"issue":"10","key":"1977_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13357","volume":"18","author":"H Chemaitelly","year":"2024","unstructured":"Chemaitelly H, Ayoub HH, Coyle P, Tang P, Hasan MR, Yassine HM, et al. BNT162b2 versus mRNA-1273 vaccines: comparative analysis of long-term protection against SARS-CoV-2 infection and severe COVID-19 in Qatar. Influenza Other Respir Viruses. 2024;18(10):e13357. https:\/\/doi.org\/10.1111\/irv.13357.","journal-title":"Influenza Other Respir Viruses"},{"issue":"27","key":"1977_CR11","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315. https:\/\/doi.org\/10.1056\/NEJMoa2034577.","journal-title":"N Engl J Med"},{"issue":"5","key":"1977_CR12","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403\u201316. https:\/\/doi.org\/10.1056\/NEJMoa2035389.","journal-title":"N Engl J Med"},{"issue":"6","key":"1977_CR13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","volume":"20","author":"MG Netea","year":"2020","unstructured":"Netea MG, Dominguez-Andres J, Barreiro LB, Chavakis T, Divangahi M, Fuchs E, et al. Defining trained immunity and its role in health and disease. Nat Rev Immunol. 2020;20(6):375\u201388. https:\/\/doi.org\/10.1038\/s41577-020-0285-6.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"1977_CR14","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1016\/j.celrep.2016.11.011","volume":"17","author":"RJW Arts","year":"2016","unstructured":"Arts RJW, Carvalho A, La Rocca C, Palma C, Rodrigues F, Silvestre R, et al. Immunometabolic pathways in BCG-induced trained immunity. Cell Rep. 2016;17(10):2562\u201371. https:\/\/doi.org\/10.1016\/j.celrep.2016.11.011.","journal-title":"Cell Rep"},{"issue":"3","key":"1977_CR15","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/ije\/dyh392","volume":"34","author":"A Roth","year":"2005","unstructured":"Roth A, Gustafson P, Nhaga A, Djana Q, Poulsen A, Garly ML, Jensen H, Sodemann M, Rodriques A, Aaby P. BCG vaccination scar associated with better childhood survival in Guinea-Bissau. Int J Epidemiol. 2005;34(3):540\u20137. https:\/\/doi.org\/10.1093\/ije\/dyh392.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"1977_CR16","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/ije\/dyw120","volume":"46","author":"A Rieckmann","year":"2017","unstructured":"Rieckmann A, Villumsen M, Sorup S, Haugaard LK, Ravn H, Roth A, Baker JL, Benn CS, Aaby P. Vaccinations against smallpox and tuberculosis are associated with better long-term survival: a Danish case-cohort study 1971\u20132010. Int J Epidemiol. 2017;46(2):695\u2013705. https:\/\/doi.org\/10.1093\/ije\/dyw120.","journal-title":"Int J Epidemiol"},{"issue":"7","key":"1977_CR17","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/cid\/cix525","volume":"65","author":"S Biering-Sorensen","year":"2017","unstructured":"Biering-Sorensen S, Aaby P, Lund N, Monteiro I, Jensen KJ, Eriksen HB, et al. Early BCG-Denmark and neonatal mortality among infants weighing\u2009<\u20092500\u00a0g: a randomized controlled trial. Clin Infect Dis. 2017;65(7):1183\u201390. https:\/\/doi.org\/10.1093\/cid\/cix525.","journal-title":"Clin Infect Dis"},{"key":"1977_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.vaccine.2006.04.045","volume":"24","author":"P Aaby","year":"2006","unstructured":"Aaby P, Gustafson P, Roth A, Rodrigues A, Fernandes M, Sodemann M, Holmgren B, Benn CS, Garly ML, Lisse IM, Jensen H. Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau. Vaccine. 2006;24:29\u201330. https:\/\/doi.org\/10.1016\/j.vaccine.2006.04.045.","journal-title":"Vaccine"},{"issue":"1","key":"1977_CR19","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1371\/journal.pone.0000101","volume":"1","author":"ML Jensen","year":"2006","unstructured":"Jensen ML, Dave S, Schim M, van der Loeff C, da Costa T, Vincent A, et al. Vaccinia scars associated with improved survival among adults in rural Guinea-Bissau. PLoS One. 2006;1(1):e101. https:\/\/doi.org\/10.1371\/journal.pone.0000101.","journal-title":"PLoS One"},{"key":"1977_CR20","doi-asserted-by":"publisher","first-page":"c6495","DOI":"10.1136\/bmj.c6495","volume":"341","author":"P Aaby","year":"2010","unstructured":"Aaby P, Martins CL, Garly ML, Bale C, Andersen A, Rodrigues A, Ravn H, Lisse IM, Benn CS, Whittle HC. Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial. BMJ. 2010;341:c6495. https:\/\/doi.org\/10.1136\/bmj.c6495.","journal-title":"BMJ"},{"issue":"10","key":"1977_CR21","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1093\/cid\/ciaa1351","volume":"72","author":"A Andersen","year":"2021","unstructured":"Andersen A, Fisker AB, Nielsen S, Rodrigues A, Benn CS, Aaby P. National immunization campaigns with oral polio vaccine may reduce all-cause mortality: an analysis of 13 years of demographic surveillance data from an urban African area. Clin Infect Dis. 2021;72(10):e596\u2013603. https:\/\/doi.org\/10.1093\/cid\/ciaa1351.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1977_CR22","doi-asserted-by":"publisher","first-page":"e553","DOI":"10.1542\/peds.2006-2836","volume":"120","author":"PA Piedra","year":"2007","unstructured":"Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP. Trivalent live attenuated intranasal influenza vaccine administered during the 2003\u20132004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children. Pediatrics. 2007;120(3):e553\u201364. https:\/\/doi.org\/10.1542\/peds.2006-2836.","journal-title":"Pediatrics"},{"key":"1977_CR23","doi-asserted-by":"publisher","unstructured":"Quintin J, Saeed S, Martens JHA, Giamarellos-Bourboulis EJ, Ifrim DC, Logie C, Jacobs L, Jansen T, Kullberg BJ, Wijmenga C, Joosten LAB, Xavier RJ, van der Meer JWM, Stunnenberg HG, Netea MG. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe. 2012;12(2). https:\/\/doi.org\/10.1016\/j.chom.2012.06.006. 223\u2009\u2013\u200932.","DOI":"10.1016\/j.chom.2012.06.006"},{"key":"1977_CR24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI162581","author":"DM Murphy","year":"2023","unstructured":"Murphy DM, Cox DJ, Connolly SA, Breen EP, Brugman AA, Phelan JJ, et al. Trained immunity is induced in humans after immunization with an adenoviral vector COVID-19 vaccine. J Clin Invest. 2023. https:\/\/doi.org\/10.1172\/JCI162581.","journal-title":"J Clin Invest"},{"issue":"2","key":"1977_CR25","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/infdis\/jiad422","volume":"229","author":"AMR Madsen","year":"2024","unstructured":"Madsen AMR, Schaltz-Buchholzer F, Nielsen S, Benfield T, Bjerregaard-Andersen M, Dalgaard LS, et al. Using BCG vaccine to enhance nonspecific protection of health care workers during the COVID-19 pandemic: a randomized controlled trial. J Infect Dis. 2024;229(2):384\u201393. https:\/\/doi.org\/10.1093\/infdis\/jiad422.","journal-title":"J Infect Dis"},{"issue":"4","key":"1977_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","volume":"21","author":"JR Teijaro","year":"2021","unstructured":"Teijaro JR, Farber DL. COVID-19 vaccines: modes of immune activation and future challenges. Nat Rev Immunol. 2021;21(4):195\u20137. https:\/\/doi.org\/10.1038\/s41577-021-00526-x.","journal-title":"Nat Rev Immunol"},{"key":"1977_CR27","doi-asserted-by":"publisher","unstructured":"Yamaguchi Y, Kato Y, Edahiro R, Sondergaard JN, Murakami T, Amiya S, Nameki S, Yoshimine Y, Morita T, Takeshima Y, Sakakibara S, Naito Y, Motooka D, Liu YC, Shirai Y, Okita Y, Fujimoto J, Hirata H, Takeda Y, Kumanogoh A. Consecutive BNT162b2 mRNA vaccination induces short-term epigenetic memory in innate immune cells. JCI Insight. 2022;7(22). https:\/\/doi.org\/10.1172\/jci.insight.163347.","DOI":"10.1172\/jci.insight.163347"},{"key":"1977_CR28","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.175401","author":"F Hellgren","year":"2024","unstructured":"Hellgren F, Rosdahl A, Arcoverde Cerveira R, Lenart K, Ols S, Gwon YD, et al. Modulation of innate immune response to mRNA vaccination after SARS-CoV-2 infection or sequential vaccination in humans. JCI Insight. 2024. https:\/\/doi.org\/10.1172\/jci.insight.175401.","journal-title":"JCI Insight"},{"key":"1977_CR29","doi-asserted-by":"publisher","first-page":"109762","DOI":"10.1016\/j.clim.2023.109762","volume":"255","author":"K Fohse","year":"2023","unstructured":"Fohse K, Geckin B, Zoodsma M, Kilic G, Liu Z, Roring RJ, Overheul GJ, van de Maat J, Bulut O, Hoogerwerf JJ, Ten Oever J, Simonetti E, Schaal H, Adams O, Muller L, Ostermann PN, van de Veerdonk FL, Joosten LAB, Haagmans BL, Netea MG. The impact of BNT162b2 mRNA vaccine on adaptive and innate immune responses. Clin Immunol. 2023;255:109762. https:\/\/doi.org\/10.1016\/j.clim.2023.109762.","journal-title":"Clin Immunol"},{"key":"1977_CR30","doi-asserted-by":"publisher","first-page":"1242380","DOI":"10.3389\/fimmu.2023.1242380","volume":"14","author":"A Noe","year":"2023","unstructured":"Noe A, Dang TD, Axelrad C, Burrell E, Germano S, Elia S, Burgner D, Perrett KP, Curtis N, Messina NL. BNT162b2 COVID-19 vaccination in children alters cytokine responses to heterologous pathogens and Toll-like receptor agonists. Front Immunol. 2023;14:1242380. https:\/\/doi.org\/10.3389\/fimmu.2023.1242380.","journal-title":"Front Immunol"},{"key":"1977_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105100","volume":"103","author":"NL Messina","year":"2024","unstructured":"Messina NL, Germano S, McElroy R, Bonnici R, Grubor-Bauk B, Lynn DJ, et al. Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines-an exploratory sub-study of the BRACE trial. EBioMedicine. 2024;103:105100. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105100.","journal-title":"EBioMedicine"},{"issue":"8","key":"1977_CR32","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.cmi.2022.03.003","volume":"28","author":"OS Sogaard","year":"2022","unstructured":"Sogaard O.S., Reekie J., Johansen I.S., Nielsen H., Benfield T., Wiese L., Staerke N.B., Iversen K., Fogh K., Bodilsen J., Iversen M., Knudsen L.S., Klastrup V., Larsen F.D., Andersen S.D., Hvidt A.K., Andreasen S.R., Madsen L.W., Lindvig S.O., Group E.W. Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study. Clin Microbiol Infect. 2022;28(8):1126\u201333. https:\/\/doi.org\/10.1016\/j.cmi.2022.03.003.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"1977_CR33","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.1038\/s41467-022-32254-8","volume":"13","author":"NB Staerke","year":"2022","unstructured":"Staerke N.B., Reekie J., Nielsen H., Benfield T., Wiese L., Knudsen L.S., Iversen M.B., Iversen K., Fogh K., Bodilsen J., Juhl M.R., Lindvig S.O., Ovrehus A., Madsen L.W., Klastrup V., Andersen S.D., Juhl A.K., Andreasen S.R., Ostrowski S.R., Sogaard O.S. Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections. Nat Commun. 2022;13(1):4466. https:\/\/doi.org\/10.1038\/s41467-022-32254-8.","journal-title":"Nat Commun"},{"key":"1977_CR34","doi-asserted-by":"publisher","unstructured":"L.L. Dietz, A.K. Juhl, O.S. Sogaard, J. Reekie, H. Nielsen, I.S. Johansen, T. Benfield,L. Wiese, N.B. Staerke, T.O. Jensen, S.F. Jakobsen, R. Olesen, K. Iversen, K. Fogh,J. Bodilsen, K.T. Petersen, L. Larsen, L.W. Madsen, S.O. Lindvig, \u2026 E.S. Group, Impact of age and comorbidities on SARS-CoV-2 vaccine-induced T cell immunity, Commun Med(Lond) 3(1) (2023) 58. https:\/\/doi.org\/10.1038\/s43856-023-00277-x.","DOI":"10.1038\/s43856-023-00277-x"},{"issue":"1","key":"1977_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70027","volume":"14","author":"A Borup","year":"2025","unstructured":"Borup A, Sharifpour MF, Rossen LS, Whitehead B, Boysen AT, Olesen R, et al. Helminth extracellular vesicles co-opt host monocytes to drive T cell anergy. J Extracell Vesicles. 2025;14(1):e70027. https:\/\/doi.org\/10.1002\/jev2.70027.","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"1977_CR36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12967-023-03944-8","volume":"21","author":"J Chen","year":"2023","unstructured":"Chen J, Gao L, Wu X, Fan Y, Liu M, Peng L, Song J, Li B, Liu A, Bao F. BCG-induced trained immunity: history, mechanisms and potential applications. J Transl Med. 2023;21(1):106. https:\/\/doi.org\/10.1186\/s12967-023-03944-8.","journal-title":"J Transl Med"},{"issue":"1","key":"1977_CR37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.immuni.2020.10.011","volume":"54","author":"S Fanucchi","year":"2021","unstructured":"Fanucchi S, Dominguez-Andres J, Joosten LAB, Netea MG, Mhlanga MM. The intersection of epigenetics and metabolism in trained immunity. Immunity. 2021;54(1):32\u201343. https:\/\/doi.org\/10.1016\/j.immuni.2020.10.011.","journal-title":"Immunity"},{"key":"1977_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.745332","volume":"12","author":"OA Acevedo","year":"2021","unstructured":"Acevedo OA, Berrios RV, Rodriguez-Guilarte L, Lillo-Dapremont B, Kalergis AM. Molecular and cellular mechanisms modulating trained immunity by various cell types in response to pathogen encounter. Front Immunol. 2021;12:745332. https:\/\/doi.org\/10.3389\/fimmu.2021.745332.","journal-title":"Front Immunol"},{"issue":"7872","key":"1977_CR39","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41586-021-03791-x","volume":"596","author":"PS Arunachalam","year":"2021","unstructured":"Arunachalam P.S., Scott M.K.D., Hagan T., Li C., Feng Y., Wimmers F., Grigoryan L., Trisal M., Edara V.V., Lai L., Chang S.E., Feng A., Dhingra S., Shah M., Lee A.S., Chinthrajah S., Sindher S.B., Mallajosyula V., Gao F., Pulendran B. Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature. 2021;596(7872):410\u20136. https:\/\/doi.org\/10.1038\/s41586-021-03791-x.","journal-title":"Nature"},{"key":"1977_CR40","doi-asserted-by":"publisher","first-page":"947320","DOI":"10.3389\/fimmu.2022.947320","volume":"13","author":"M Saresella","year":"2022","unstructured":"Saresella M, Piancone F, Marventano I, Hernis A, Trabattoni D, Invernizzi M, La Rosa F, Clerici M. Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine. Front Immunol. 2022;13:947320. https:\/\/doi.org\/10.3389\/fimmu.2022.947320.","journal-title":"Front Immunol"},{"issue":"1","key":"1977_CR41","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/imr.13326","volume":"323","author":"P Vuscan","year":"2024","unstructured":"Vuscan P, Kischkel B, Joosten LAB, Netea MG. Trained immunity: general and emerging concepts. Immunol Rev. 2024;323(1):164\u201385. https:\/\/doi.org\/10.1111\/imr.13326.","journal-title":"Immunol Rev"},{"issue":"1","key":"1977_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41581-022-00633-5","volume":"19","author":"J Ochando","year":"2023","unstructured":"Ochando J, Mulder WJM, Madsen JC, Netea MG, Duivenvoorden R. Trained immunity - basic concepts and contributions to immunopathology. Nat Rev Nephrol. 2023;19(1):23\u201337. https:\/\/doi.org\/10.1038\/s41581-022-00633-5.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"1977_CR43","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/jir.2008.0027","volume":"29","author":"SL Deshmane","year":"2009","unstructured":"Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009;29(6):313\u201326. https:\/\/doi.org\/10.1089\/jir.2008.0027.","journal-title":"J Interferon Cytokine Res"},{"issue":"7","key":"1977_CR44","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41423-023-01013-0","volume":"20","author":"T Yoshimura","year":"2023","unstructured":"Yoshimura T, Li C, Wang Y, Matsukawa A. The chemokine monocyte chemoattractant protein-1\/CCL2 is a promoter of breast cancer metastasis. Cell Mol Immunol. 2023;20(7):714\u201338. https:\/\/doi.org\/10.1038\/s41423-023-01013-0.","journal-title":"Cell Mol Immunol"},{"key":"1977_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109130","volume":"111","author":"M Aliyu","year":"2022","unstructured":"Aliyu M, Zohora FT, Anka AU, Ali K, Maleknia S, Saffarioun M, et al. Interleukin-6 cytokine: an overview of the immune regulation, immune dysregulation, and therapeutic approach. Int Immunopharmacol. 2022;111:109130. https:\/\/doi.org\/10.1016\/j.intimp.2022.109130.","journal-title":"Int Immunopharmacol"},{"key":"1977_CR46","doi-asserted-by":"publisher","DOI":"10.1172\/JCI171742","author":"NE Stevens","year":"2023","unstructured":"Stevens NE, Ryan FJ, Messina NL, Blake SJ, Norton TS, Germano S, et al. No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines. J Clin Invest. 2023. https:\/\/doi.org\/10.1172\/JCI171742.","journal-title":"J Clin Invest"},{"issue":"1","key":"1977_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-35731-2","volume":"13","author":"D Langgartner","year":"2023","unstructured":"Langgartner D, Winkler R, Brunner-Weisser J, Rohleder N, Jarczok MN, Gundel H, et al. COVID-19 vaccination exacerbates ex vivo IL-6 release from isolated PBMCs. Sci Rep. 2023;13(1):9496. https:\/\/doi.org\/10.1038\/s41598-023-35731-2.","journal-title":"Sci Rep"},{"key":"1977_CR48","doi-asserted-by":"publisher","unstructured":"Cabau G, Badii M, Mirea AM, Gaal OI, van Emst L, Popp RA, Crisan TO, Joosten LAB. Long-Lasting Enhanced Cytokine Responses Following SARS-CoV-2 BNT162b2 mRNA Vaccination. Vaccines (Basel). 2024;12(7). https:\/\/doi.org\/10.3390\/vaccines12070736.","DOI":"10.3390\/vaccines12070736"},{"issue":"43","key":"1977_CR49","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.1202870109","volume":"109","author":"J Kleinnijenhuis","year":"2012","unstructured":"Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Ifrim DC, Saeed S, et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A. 2012;109(43):17537\u201342. https:\/\/doi.org\/10.1073\/pnas.1202870109.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1977_CR50","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","volume":"23","author":"RJW Arts","year":"2018","unstructured":"Arts RJW, Moorlag S, Novakovic B, Li Y, Wang SY, Oosting M, et al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe. 2018;23(1):89\u2013100 e5. https:\/\/doi.org\/10.1016\/j.chom.2017.12.010.","journal-title":"Cell Host Microbe"},{"issue":"7","key":"1977_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107634","volume":"31","author":"S Moorlag","year":"2020","unstructured":"Moorlag S, Khan N, Novakovic B, Kaufmann E, Jansen T, van Crevel R, et al. beta-Glucan induces protective trained immunity against Mycobacterium tuberculosis infection: a key role for IL-1. Cell Rep. 2020;31(7):107634. https:\/\/doi.org\/10.1016\/j.celrep.2020.107634.","journal-title":"Cell Rep"},{"issue":"5","key":"1977_CR52","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jiac.2023.11.020","volume":"30","author":"T Nakayama","year":"2024","unstructured":"Nakayama T, Todaka R, Sawada A, Ito T, Fujino M, Haga K, Katayama K. Different immunological responses following immunization with two mRNA vaccines. J Infect Chemother. 2024;30(5):439\u201349. https:\/\/doi.org\/10.1016\/j.jiac.2023.11.020.","journal-title":"J Infect Chemother"},{"issue":"4","key":"1977_CR53","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","volume":"23","author":"C Li","year":"2022","unstructured":"Li C., Lee A., Grigoryan L., Arunachalam P.S., Scott M.K.D., Trisal M., Wimmers F., Sanyal M., Weidenbacher P.A., Feng Y., Adamska J.Z., Valore E., Wang Y., Verma R., Reis N., Dunham D., O\u2019Hara R., Park H., Luo W., Pulendran B. Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine. Nat Immunol. 2022;23(4):543\u201355. https:\/\/doi.org\/10.1038\/s41590-022-01163-9.","journal-title":"Nat Immunol"},{"issue":"2","key":"1977_CR54","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","volume":"23","author":"K Kariko","year":"2005","unstructured":"Kariko K, Buckstein M, Ni H, Weissman D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity. 2005;23(2):165\u201375. https:\/\/doi.org\/10.1016\/j.immuni.2005.06.008.","journal-title":"Immunity"},{"issue":"5","key":"1977_CR55","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1021\/acscentsci.1c00197","volume":"7","author":"KD Nance","year":"2021","unstructured":"Nance KD, Meier JL. Modifications in an emergency: the role of N1-methylpseudouridine in COVID-19 vaccines. ACS Cent Sci. 2021;7(5):748\u201356. https:\/\/doi.org\/10.1021\/acscentsci.1c00197.","journal-title":"ACS Cent Sci"},{"key":"1977_CR56","doi-asserted-by":"publisher","first-page":"789427","DOI":"10.3389\/fcell.2021.789427","volume":"9","author":"P Morais","year":"2021","unstructured":"Morais P, Adachi H, Yu YT. The critical contribution of pseudouridine to mRNA COVID-19 vaccines. Front Cell Dev Biol. 2021;9:789427. https:\/\/doi.org\/10.3389\/fcell.2021.789427.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"1977_CR57","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41565-023-01404-4","volume":"18","author":"X Han","year":"2023","unstructured":"Han X, Alameh MG, Butowska K, Knox JJ, Lundgreen K, Ghattas M, Gong N, Xue L, Xu Y, Lavertu M, Bates P, Xu J, Nie G, Zhong Y, Weissman D, Mitchell MJ. Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines. Nat Nanotechnol. 2023;18(9):1105\u201314. https:\/\/doi.org\/10.1038\/s41565-023-01404-4.","journal-title":"Nat Nanotechnol"},{"issue":"12","key":"1977_CR58","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","volume":"54","author":"MG Alameh","year":"2021","unstructured":"Alameh MG, Tombacz I, Bettini E, Lederer K, Sittplangkoon C, Wilmore JR, et al. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses. Immunity. 2021;54(12):2877\u20132892 e7. https:\/\/doi.org\/10.1016\/j.immuni.2021.11.001.","journal-title":"Immunity"},{"key":"1977_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","volume":"15","author":"KJ Hassett","year":"2019","unstructured":"Hassett KJ, Benenato KE, Jacquinet E, Lee A, Woods A, Yuzhakov O, et al. Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines. Mol Ther Nucleic Acids. 2019;15:1\u201311. https:\/\/doi.org\/10.1016\/j.omtn.2019.01.013.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"7","key":"1977_CR60","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1021\/acs.nanolett.2c04883","volume":"23","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Yan J, Hou X, Wang C, Kang DD, Xue Y, et al. STING agonist-derived LNP-mRNA vaccine enhances protective immunity against SARS-CoV-2. Nano Lett. 2023;23(7):2593\u2013600. https:\/\/doi.org\/10.1021\/acs.nanolett.2c04883.","journal-title":"Nano Lett"},{"issue":"1","key":"1977_CR61","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41590-020-00845-6","volume":"22","author":"M Divangahi","year":"2021","unstructured":"Divangahi M, Aaby P, Khader SA, Barreiro LB, Bekkering S, Chavakis T, et al. Trained immunity, tolerance, priming and differentiation: distinct immunological processes. Nat Immunol. 2021;22(1):2\u20136. https:\/\/doi.org\/10.1038\/s41590-020-00845-6.","journal-title":"Nat Immunol"},{"key":"1977_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032700","author":"V Gote","year":"2023","unstructured":"Gote V, Bolla PK, Kommineni N, Butreddy A, Nukala PK, Palakurthi SS, et al. A comprehensive review of mRNA vaccines. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24032700.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1977_CR63","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.ymthe.2018.03.010","volume":"26","author":"S Sabnis","year":"2018","unstructured":"Sabnis S, Kumarasinghe ES, Salerno T, Mihai C, Ketova T, Senn JJ, et al. A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharmacology and safety in non-human primates. Mol Ther. 2018;26(6):1509\u201319. https:\/\/doi.org\/10.1016\/j.ymthe.2018.03.010.","journal-title":"Mol Ther"},{"key":"1977_CR64","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.addr.2020.07.001","volume":"154","author":"H Tanaka","year":"2020","unstructured":"Tanaka H, Sakurai Y, Anindita J, Akita H. Development of lipid-like materials for RNA delivery based on intracellular environment-responsive membrane destabilization and spontaneous collapse. Adv Drug Deliv Rev. 2020;154:210\u201326. https:\/\/doi.org\/10.1016\/j.addr.2020.07.001.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"1977_CR65","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41541-023-00751-6","volume":"8","author":"L Zhang","year":"2023","unstructured":"Zhang L, More KR, Ojha A, Jackson CB, Quinlan BD, Li H, He W, Farzan M, Pardi N, Choe H. Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability. NPJ Vaccines. 2023;8(1):156. https:\/\/doi.org\/10.1038\/s41541-023-00751-6.","journal-title":"NPJ Vaccines"},{"issue":"16","key":"1977_CR66","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/j.vaccine.2021.03.038","volume":"39","author":"SS Rosa","year":"2021","unstructured":"Rosa SS, Prazeres DMF, Azevedo AM, Marques MPC. mRNA vaccines manufacturing: challenges and bottlenecks. Vaccine. 2021;39(16):2190\u2013200. https:\/\/doi.org\/10.1016\/j.vaccine.2021.03.038.","journal-title":"Vaccine"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-025-01977-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01977-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01977-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T17:03:13Z","timestamp":1768842193000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-025-01977-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1977"],"URL":"https:\/\/doi.org\/10.1007\/s10875-025-01977-w","relation":{},"ISSN":["1573-2592"],"issn-type":[{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Danish Medicines Agency (#2020-006003-42), and the National Committee on Health Research Ethics (#1-10-72-337-20). All participants provided informed written consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}